Glycosylated-drug Delivery as Targeted Therapy for Hepatocellular Carcinoma: Are We There Yet?

Autor: Sukowati CHC; Liver Cancer Unit, Italian Liver Foundation NPO, AREA Science Park, Basovizza, Trieste 34149, Italy.; Eijkman Research Center for Molecular Biology, National Research and Innovation Agency of Indonesia (BRIN), B.J. Habibie Building, Jl. M.H. Thamrin No. 8, Jakarta Pusat 10340, Indonesia., Weiz G; Institute of Earth and Environmental Sciences from La Pampa (INCITAP), School of Natural Sciences (CONICET-UNLPam), National University of La Pampa, Santa Rosa 6300, La Pampa, Argentina., Lestari WW; Chemistry Department, Faculty of Mathematics and Natural Sciences, Universitas Sebelas Maret, Jl Ir. Sutami 36A, Surakarta 57126, Indonesia., Tiribelli C; Liver Cancer Unit, Italian Liver Foundation NPO, AREA Science Park, Basovizza, Trieste 34149, Italy.
Jazyk: angličtina
Zdroj: Current pharmaceutical design [Curr Pharm Des] 2023; Vol. 29 (31), pp. 2439-2441.
DOI: 10.2174/0113816128269619231018074301
Databáze: MEDLINE